Table 5

Specific KRAS mutations associated with progression to intestinal metaplasia

Mutation typeNo change or regressionProgressionaUnivariate OR (P = 0.004)b
None85.3% (116/136)14.7% (20/136)1.0
TGT70.6% (12/17)19.4% (5/17)2.4
AGT and A/TGT40.0% (2/5)60.0% (3/5)8.7
Total82.3% (130/158)17.7% (28/158)
  • a Progression from atrophy to intestinal metaplasia.

  • b Using χ2 test.